Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: POF1B

Gene summary for POF1B

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

POF1B

Gene ID

79983

Gene namePOF1B actin binding protein
Gene AliasPOF
CytomapXq21.1
Gene Typeprotein-coding
GO ID

GO:0000902

UniProtAcc

Q8WVV4


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
79983POF1BHTA11_3410_2000001011HumanColorectumAD3.63e-17-5.59e-010.0155
79983POF1BHTA11_2951_2000001011HumanColorectumAD1.39e-03-5.58e-010.0216
79983POF1BHTA11_1938_2000001011HumanColorectumAD2.94e-045.92e-01-0.0811
79983POF1BHTA11_347_2000001011HumanColorectumAD1.76e-147.09e-01-0.1954
79983POF1BHTA11_3361_2000001011HumanColorectumAD1.13e-06-5.21e-01-0.1207
79983POF1BHTA11_866_3004761011HumanColorectumAD4.44e-11-5.84e-010.096
79983POF1BHTA11_7696_3000711011HumanColorectumAD3.43e-04-3.41e-010.0674
79983POF1BHTA11_6818_2000001021HumanColorectumAD1.29e-07-5.64e-010.0588
79983POF1BHTA11_99999970781_79442HumanColorectumMSS5.35e-05-4.60e-010.294
79983POF1BHTA11_99999965104_69814HumanColorectumMSS9.92e-056.24e-010.281
79983POF1BHTA11_99999971662_82457HumanColorectumMSS1.23e-09-5.05e-010.3859
79983POF1BHTA11_99999974143_84620HumanColorectumMSS1.87e-17-5.61e-010.3005
79983POF1BF007HumanColorectumFAP2.49e-115.22e-010.1176
79983POF1BA002-C-010HumanColorectumFAP1.36e-225.23e-010.242
79983POF1BA015-C-203HumanColorectumFAP2.21e-271.58e-01-0.1294
79983POF1BA015-C-204HumanColorectumFAP8.73e-082.44e-01-0.0228
79983POF1BA014-C-040HumanColorectumFAP3.58e-115.12e-01-0.1184
79983POF1BA002-C-201HumanColorectumFAP1.20e-163.27e-010.0324
79983POF1BA002-C-203HumanColorectumFAP4.83e-165.26e-010.2786
79983POF1BA001-C-119HumanColorectumFAP1.41e-02-6.65e-02-0.1557
Page: 1 2 3 4 5 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:0007015ColorectumADactin filament organization167/3918442/187231.65e-167.94e-14167
GO:0002064ColorectumADepithelial cell development89/3918220/187232.98e-113.52e-0989
GO:0045216ColorectumADcell-cell junction organization80/3918200/187235.57e-104.58e-0880
GO:0034329ColorectumADcell junction assembly136/3918420/187232.02e-081.15e-06136
GO:0007043ColorectumADcell-cell junction assembly57/3918146/187234.18e-071.61e-0557
GO:0043297ColorectumADapical junction assembly34/391878/187235.31e-061.37e-0434
GO:0120193ColorectumADtight junction organization33/391880/187232.93e-055.42e-0433
GO:0120192ColorectumADtight junction assembly31/391874/187233.53e-056.43e-0431
GO:0070830ColorectumADbicellular tight junction assembly28/391870/187232.15e-042.83e-0328
GO:00070152ColorectumMSSactin filament organization146/3467442/187231.16e-132.67e-11146
GO:00020642ColorectumMSSepithelial cell development81/3467220/187231.02e-101.06e-0881
GO:00452162ColorectumMSScell-cell junction organization69/3467200/187235.07e-082.70e-0669
GO:00343292ColorectumMSScell junction assembly120/3467420/187232.51e-071.07e-05120
GO:00070432ColorectumMSScell-cell junction assembly50/3467146/187234.24e-061.21e-0450
GO:00432972ColorectumMSSapical junction assembly28/346778/187232.12e-042.95e-0328
GO:01201932ColorectumMSStight junction organization27/346780/187238.31e-048.68e-0327
GO:01201922ColorectumMSStight junction assembly25/346774/187231.25e-031.20e-0225
GO:00708302ColorectumMSSbicellular tight junction assembly22/346770/187236.42e-034.27e-0222
GO:00070154ColorectumFAPactin filament organization125/2622442/187231.97e-153.03e-12125
GO:00343293ColorectumFAPcell junction assembly105/2622420/187231.03e-092.18e-07105
Page: 1 2 3 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
Page: 1 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
POF1BSNVMissense_Mutationnovelc.1469N>Tp.Ser490Leup.S490LQ8WVV4protein_codingdeleterious(0)probably_damaging(0.985)TCGA-A8-A081-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
POF1BSNVMissense_Mutationc.169N>Tp.Gly57Trpp.G57WQ8WVV4protein_codingdeleterious_low_confidence(0)probably_damaging(1)TCGA-A8-A09Z-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
POF1BSNVMissense_Mutationc.553C>Gp.Gln185Glup.Q185EQ8WVV4protein_codingtolerated_low_confidence(0.09)benign(0.037)TCGA-AC-A23C-01Breastbreast invasive carcinomaFemale<65I/IIChemotherapychemoCR
POF1BSNVMissense_Mutationnovelc.842G>Tp.Arg281Ilep.R281IQ8WVV4protein_codingdeleterious(0)possibly_damaging(0.653)TCGA-AN-A046-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
POF1BSNVMissense_Mutationc.394N>Ap.Pro132Thrp.P132TQ8WVV4protein_codingtolerated_low_confidence(0.1)probably_damaging(0.998)TCGA-EW-A3U0-01Breastbreast invasive carcinomaFemale<65III/IVChemotherapycisplatinCR
POF1BdeletionFrame_Shift_Delnovelc.1744delAp.Thr582GlnfsTer8p.T582Qfs*8Q8WVV4protein_codingTCGA-D8-A27V-01Breastbreast invasive carcinomaFemale<65I/IIHormone TherapytamoxiphenSD
POF1BSNVMissense_Mutationnovelc.1144N>Tp.Ala382Serp.A382SQ8WVV4protein_codingdeleterious(0.02)benign(0.092)TCGA-2W-A8YY-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
POF1BSNVMissense_Mutationrs769700681c.797N>Ap.Arg266Hisp.R266HQ8WVV4protein_codingdeleterious(0.05)probably_damaging(0.997)TCGA-2W-A8YY-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
POF1BSNVMissense_Mutationnovelc.368N>Tp.Ser123Phep.S123FQ8WVV4protein_codingtolerated_low_confidence(0.08)probably_damaging(0.994)TCGA-2W-A8YY-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
POF1BSNVMissense_Mutationnovelc.922G>Ap.Glu308Lysp.E308KQ8WVV4protein_codingdeleterious(0)benign(0.269)TCGA-EX-A1H6-01Cervixcervical & endocervical cancerFemale<65I/IIUnknownUnknownSD
Page: 1 2 3 4 5 6 7 8 9 10 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1